Cargando…
Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial
OBJECTIVES: Mappings to convert clinical measures to preference-based measures of health such as the EQ-5D-3L are sometimes required in cost-utility analyses. We developed mappings to convert best-corrected visual acuity (BCVA) to the EQ-5D-3L, the EQ-5D-3L with a vision bolt-on (EQ-5D V), and the V...
Autores principales: | Pennington, Becky M., Hernández-Alava, Mónica, Hykin, Philip, Sivaprasad, Sobha, Flight, Laura, Alshreef, Abualbishr, Brazier, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427317/ https://www.ncbi.nlm.nih.gov/pubmed/32762995 http://dx.doi.org/10.1016/j.jval.2020.03.008 |
Ejemplares similares
-
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
por: Pennington, Becky, et al.
Publicado: (2021) -
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
por: Pennington, Becky, et al.
Publicado: (2021) -
An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5D
por: Yang, Yaling, et al.
Publicado: (2015) -
Developing and testing a cognitive bolt-on for the EQ-5D-Y (Youth)
por: Ludwig, Kristina, et al.
Publicado: (2021) -
Criteria for developing, assessing and selecting candidate EQ-5D bolt-ons
por: Mulhern, Brendan J., et al.
Publicado: (2022)